SFM
Sphera Funds Management Portfolio holdings
AUM
$382M
1-Year Return
0.41%
This Quarter Return
+3.52%
1 Year Return
+0.41%
3 Year Return
+99.29%
5 Year Return
+177.09%
10 Year Return
+575.73%
AUM
$842M
AUM Growth
-$167M
(-17%)
Cap. Flow
-$185M
Cap. Flow
% of AUM
-22.02%
Top 10 Holdings %
Top 10 Hldgs %
43.02%
Holding
132
New
22
Increased
18
Reduced
31
Closed
44
Top Buys
| 1 |
Merck
MRK
|
$26.6M |
| 2 |
Amazon
AMZN
|
$13.5M |
| 3 |
Burlington
BURL
|
$12.1M |
| 4 |
Sanofi
SNY
|
$12M |
| 5 |
FIVE9
FIVN
|
$11.7M |
Top Sells
| 1 |
Eli Lilly
LLY
|
$52.2M |
| 2 |
Pfizer
PFE
|
$51.8M |
| 3 |
AbbVie
ABBV
|
$17.9M |
| 4 |
Johnson & Johnson
JNJ
|
$14.3M |
| 5 |
AstraZeneca
AZN
|
$13.8M |
Sector Composition
| 1 | Healthcare | 74.17% |
| 2 | Technology | 9.76% |
| 3 | Consumer Discretionary | 5.09% |
| 4 | Communication Services | 3.02% |
| 5 | Industrials | 2.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Verint Systems
VRNT
$1.23B
| $10.5M | 1.15% |
200,000
+50,000
| +33% | +$2.63M |
|
27
SentinelOne
S
$6.25B
| $10.1M | 1.11% |
+199,824
| New | +$10.1M |
|
|
ARYD
28
DELISTED
ARYA Sciences Acquisition Corp IV Class A Odinary Shares
ARYD
| $9.93M | 1.09% |
1,000,000
| – | – |
|
29
Leslie's
LESL
$64.6M
| $8.82M | 0.97% |
372,569
+222,569
| +148% | +$5.27M |
|
30
Immatics
IMTX
$761M
| $8.36M | 0.92% |
621,925
-178,118
| -22% | -$2.39M |
|
|
LENZ
31
LENZ Therapeutics
LENZ
$1.2B
| $8.24M | 0.91% |
94,742
+18,846
| +25% | +$1.64M |
|
|
ISEE
32
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $8.11M | 0.89% |
485,001
| – | – |
|
33
Airbnb
ABNB
$75.8B
| $7.94M | 0.87% |
+47,689
| New | +$7.94M |
|
34
VistaGen Therapeutics
VTGN
$109M
| $7.85M | 0.86% |
134,165
+6,667
| +5% | +$390K |
|
35
Werewolf Therapeutics
HOWL
$61.7M
| $7.72M | 0.85% |
648,391
-40,084
| -6% | -$477K |
|
|
VINC
36
DELISTED
Vincerx Pharma, Inc. Common Stock
VINC
| $7.34M | 0.81% |
36,008
+3,279
| +10% | +$668K |
|
37
Caesarstone
CSTE
$48.7M
| $7.31M | 0.8% |
644,146
| – | – |
|
38
Asana
ASAN
$3.18B
| $7.19M | 0.79% |
+96,500
| New | +$7.19M |
|
39
Zai Lab
ZLAB
$3.42B
| $7.02M | 0.77% |
111,641
-34,341
| -24% | -$2.16M |
|
40
Keros Therapeutics
KROS
$633M
| $7M | 0.77% |
+119,681
| New | +$7M |
|
41
Teva Pharmaceuticals
TEVA
$21.7B
| $6.67M | 0.73% |
832,877
-1
| -0% | -$8 |
|
42
Celldex Therapeutics
CLDX
$1.52B
| $6.44M | 0.71% |
166,766
+36,436
| +28% | +$1.41M |
|
43
Immunic
IMUX
$75.1M
| $6.38M | 0.7% |
666,602
+276,790
| +71% | +$2.65M |
|
|
TEAD
44
Teads Holding Co. Common Stock
TEAD
$155M
| $6.04M | 0.66% |
431,194
| – | – |
|
45
ESSA Pharma
EPIX
$11M
| $6M | 0.66% |
422,461
-46,941
| -10% | -$667K |
|
46
Kezar Life Sciences
KZR
$29.8M
| $5.64M | 0.62% |
+33,729
| New | +$5.64M |
|
47
IDEAYA Biosciences
IDYA
$2.38B
| $5.57M | 0.61% |
235,695
-58,924
| -20% | -$1.39M |
|
48
Perion Network
PERI
$413M
| $5.41M | 0.59% |
+225,000
| New | +$5.41M |
|
|
VRNA
49
Verona Pharma
VRNA
$9.2B
| $5.38M | 0.59% |
801,256
| – | – |
|
50
Iovance Biotherapeutics
IOVA
$901M
| $5.38M | 0.59% |
281,769
-213,040
| -43% | -$4.07M |
|